4933428G20Rik | RIKEN cDNA 4933428G20 gene
GeneMGI:1918475
Physiological systems
21 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Skeleton
19 No significant impact
3 Not tested
Data collections
Gene metrics:3Significant phenotypes
0Associated diseases
Expression examined in:73Adult tissues
0Embryo tissues
increased bone mineral content | 1 supporting dataset | 4933428G20Riktm1.1(KOMP)Vlcg | homozygote | Early adult | 5.25x10-5 | ||
increased circulating alanine transaminase level | 1 supporting dataset | 4933428G20Riktm1.1(KOMP)Vlcg | homozygote | Early adult | 5.15x10-6 | ||
increased circulating aspartate transaminase level | 1 supporting dataset | 4933428G20Riktm1.1(KOMP)Vlcg | homozygote | Early adult | 1.23x10-7 |
| | | | | | | | | |
adrenal gland | heterozygote | n/a | 0% (0/2) | 0.7% (4/570) |
aorta | heterozygote | n/a | 0% (0/2) | 0.19% (1/533) |
blood | heterozygote | n/a | 0% (0/2) | 0% (0/17) |
bone marrow | heterozygote | n/a | 0% (0/2) | 0% (0/22) |
brain | heterozygote | n/a | 0% (0/2) | 0.86% (5/579) |
brainstem | heterozygote | n/a | n/a | 0.41% (2/490) |
brown adipose tissue | heterozygote | n/a | 0% (0/2) | 0% (0/588) |
cartilage tissue | heterozygote | n/a | n/a | 0.22% (1/454) |
cecum | heterozygote | n/a | 0% (0/2) | 7.75% (22/284) |
cerebellum | heterozygote | n/a | 0% (0/2) | 0.56% (3/532) |
Human diseases caused by 4933428G20Rik mutations
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
External links
No external links available for 4933428G20Rik.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.